 |
 |
 |
|
Acute Phase
Relief for Minor Pain
New Acute Phase combines the three recommended formulas—Protrypsin©, MyoCalm©, and Inflavonoid Intensive Care© —to provide comprehensive nutritional support during the first 72 hours (Phase 1) of acute care
Protrypsin© (4 Tablets)
MyoCalm© (2 Tablets)
Inflavonoid Intensive Care© (2 Tablets)
One packet supplies:
- Protrypsin© (4 Tablets)
- Four tablets supply:
- Chymotrypsinnot less than 12,000 USP units
- Trypsinnot less than 12,000 USP units
- Raw Pancreas Concentrate200 mg
- Bromelain (4,800 GDU)267 mg
- MyoCalm© (2 Tablets)
- Two tablets supply:
- Calcium (as calcium lactate)50 mg
- Magnesium (as magnesium citrate)100 mg
- Passionflower 5.35:1 Extract (Passiflora incarnata)40 mg
- Valerian Root Extract (Valeriana officinalis)20 mg
- Inflavonoid Intensive Care© (2 Tablets)
- Two tablets supply:
- Vitamin C (as ascorbic acid)200 mg
- Boswellia Gum Extract (Boswellia serrata)400 mg
- [standardized to 70% (280 mg) boswellic acids]
- Turmeric Rhizome Extract (Curcuma longa)300 mg
- [standardized to 95% (285 mg) cucruminoids]
- Ginger Rhizome Extract (Zingiber officinale)200 mg
- [standardized to 5% (10 mg) gingerols]
- Cayenne Pepper Fruit (Capsicum annuum)50 mg
- Lemon Bioflavonoid Complex200 mg
- [standardized to 50% (100 mg) full spectrum bioflavonoids]
- Quercetin100 mg
Other Ingredients:
- (Protrypsin): Microcrystalline cellulose, bromelain, pancreatin, stearic acid, trypsin-chymotrypsin (milk), croscarmellose sodium, silica, and enteric coating. Contains: milk.
- Other Ingredients (MyoCalm): Microcrystalline cellulose, cellulose, croscarmellose sodium, stearic acid, silica, magnesium stearate, and coating (deionized water, microcrystalline cellulose, polyethelene glycol, and carrageenan).
- Other Ingredients: Microcrystalline cellulose, cellulose, stearic acid, calcium silicate, silica, croscarmellose sodium, sodium starch glycolate, magnesium stearate, and coating (deionized water, microcrystalline cellulose, polyethelene glycol, and carrageenan).
- U.S. Patent Nos. 6,534,086; 6,949,260
|
|
|
 |
|
 |
|
|
|
